PD individuals with higher CSF NfL levels above the median added an increased risk of conversion to PD-D compared with the subjects in low CSF NfL concentrations below the median (HR = 2.82, 95% CI: 1.11–7.20, p = 0.030). This evidence concerns the gene NEFL and Parkinson disease.